Phase II trial of bi-weekly cetuximab for recurrent or metastatic colorectal cancer
Phase 2
- Conditions
- recurrent or metastatic colorectal cancer
- Registration Number
- JPRN-UMIN000006452
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) without active other malignancy 2) without active infection 3) without active brain metastasis 4) without severe pulmonary diseases 5) without HBs Ag 6) without severe heart diseases 7) without pregnancy 8) without prior EGFR inhibitors 9) without other medical condition unacceptable for entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method